Aciphex administration

ACIPHEXrabeprazole sodium Delayed Release Tablets

This website contains 93189 drug listings as submitted to the Food and Drug Administration (FDA).

Aciphex -

At the present time, this Web site does not contain a complete listing of labels for approved prescription drugs.



Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or gastroesophageal reflux disease (GERD); maintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD; treatment of daytime and nhttime heartburn and other symptoms associated with GERD; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome and in combination with amoxicillin and clarithromycin to eradicate Helicobacter pylori.

AcipHex Monograph for Professionals -

Some evidence for use of proton-pump inhibitors (e.g., omeprazole) for gastric acid suppressive therapy as an adjunct in the management of upper GI Crohn’s disease†, including esophageal†, gastroduodenal†, and jejunoileal† disease. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.

Aciphex administration:

Rating: 92 / 100

Overall: 88 Rates